Susanna Gatti High, Chief Operating Officer at Dyne Therapeutics, Inc. (DYN), sold 69,737 shares at $35.01 ($2.4M) on 2024-06-21, disclosed to the SEC on 2024-06-24.
Scheduled sale ($2.4M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.01 | 29,787 | $1.0M | 42.7% |
| 2 | $35.01 | 29,787 | $1.0M | 42.7% |
| 3 | $35.33 | 10,163 | $359K | 14.7% |
| Total | $35.06 avg | 69,737 | $2.4M | 100% |
| Filing → |
| DYN | SELL | 2024-08-20 | $248K | — | Filing → |
| DYN | SELL | 2024-07-03 | $722K | — | Filing → |
| DYN | SELL | 2024-06-13 | $2.7M | — | Filing → |